Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,000 across all filing types
Latest filing 2025-03-21 Management Reports
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
3.1. UCB SA_Management Report Statutory Accounts 2024 EN Final.pdf
Management Reports Classification · 1% confidence The document explicitly states it is the "Annual report of the Board of Directors for the financial year ended 31 December 2024". It contains comprehensive financial data, discussions of major events (financing, capital increases, share transactions), proposed dividend allocation, balance sheet details, and references to the 'UCB Group Integrated Annual Report 2024'. Although it mentions that other detailed reports (like Governance, Sustainability, and Financial Risks) are included within the 'Integrated Annual Report', the primary document presented here is the statutory annual report of the parent company covering the full fiscal year and seeking approval for accounts and dividends. This aligns perfectly with the definition of an Annual Report, which is typically filed as a 10-K in the US context, or the equivalent comprehensive annual filing in other jurisdictions. Given the options, '10-K' is the closest standard classification for a comprehensive Annual Report.
2025-03-21 English
6.2. Statutory Account NBB_UCB SA_31.12.2024 _FR Final.pdf
Annual Report Classification · 1% confidence The document is a formal Belgian statutory filing ('Comptes Annuels' or Annual Accounts) for UCB SA. It contains detailed balance sheet data, identification of directors, and auditor information. While it is part of the annual reporting process, it is a specific regulatory filing of financial statements required by the Belgian Code of Companies and Associations, which falls under the category of an Annual Report (10-K equivalent in this context as it provides the full financial performance and statutory accounts). FY 2024
2025-03-21 French
2.3. Proxy General Meeting 24 April 2025 - NL - Final.pdf
AGM Information Classification · 1% confidence The document is titled "VOLMACHT VOOR DE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Proxy for the General Meeting of Shareholders) and specifies the date and time for the meeting (24 APRIL 2025 OM 11:00 UUR). It contains fields for shareholders to appoint a proxy holder and provide voting instructions on various agenda items, including the approval of the annual accounts, remuneration report, and director appointments. This document is a proxy form used to grant voting authority for an Annual General Meeting (AGM). Therefore, it falls under the AGM Information category.
2025-03-21 Dutch
4.1. UCB_SA_Statutory Auditor Report 2024 EN.pdf
Audit Report / Information Classification · 1% confidence The document is explicitly titled 'Auditor's report' and contains the 'Statutory auditor's report to the general shareholders' meeting of UCB SA on the annual accounts for the year ended 31 December 2024'. It details an 'Unqualified opinion' on the annual accounts, discusses 'Key audit matters' (like the carrying value of investments), and outlines the responsibilities of the auditor and the board regarding the financial statements. This content perfectly matches the definition of an Audit Report/Information (AR), which covers standalone audit reports, distinct from the full Annual Report (10-K) or a mere announcement of a report (RPA). FY 2024
2025-03-21 English
9.2. Explanatory Note on Remuneration_FR.pdf
Remuneration Information Classification · 1% confidence The document is titled "Note explicative sur les modifications proposées à la Politique de rémunération d'UCB" (Explanatory note on the proposed changes to UCB's Remuneration Policy). It extensively details proposed changes to the compensation structure for Non-Executive Directors, including fixed annual remuneration, committee fees, and the introduction of shareholding requirements. It compares current and proposed remuneration levels and justifies the changes based on a newly established global peer group. This content directly relates to the disclosure of executive and director compensation practices, which falls under the definition of Remuneration Information (DEF 14A in the US context, or similar proxy/governance filings detailing pay). Although the document is in French, the subject matter is clearly remuneration disclosure.
2025-03-21 French
3.3. UCB SA_Management Report Staturoy Accounts 2024 NL Final.pdf
Annual Report Classification · 1% confidence The document is titled 'Jaarverslag van de Raad van Bestuur' (Annual Report of the Board of Directors) for the fiscal year ending December 31, 2024. It contains detailed financial information, including balance sheet items, profit and loss analysis, dividend proposals, and management commentary on business activities. While it references a separate 'Integrated Annual Report' for consolidated group data, this document itself serves as the statutory annual report for the parent company (UCB NV), fulfilling the criteria for a 10-K equivalent (Annual Report). FY 2024
2025-03-21 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.